The Official Website of Dan Brown Tom Hanks, Ron Howard, Sony & Columbia Pictures return with Inferno, a film adaptation of the latest Robert Langdon thriller. Sony and Columbia Pictures return with Inferno, a film adaptation of Dan Brown's latest best-selling thriller. Tom Hanks will reprise his role as Harvard symbologist Robert Langdon, with Ron Howard directing. Howard and Brian Grazer will also produce with their Imagine Entertainment. 2015 Oscar nominee Felicity Jones (The Theory Of Everything) will co-star as Dr. Howard said, "For this film, I wanted Tom Hanks to be surrounded by an international cast of actors whose energy will underscore Robert Langdon's life-or-death peril, the high-stakes action he takes, and the global threat that he's trying to prevent. Doug Belgrad, president, Sony Pictures Entertainment Motion Picture Group added, "We're thrilled to be making a third Robert Langdon film with Ron, Tom and Brian.
If We Stay Out of Syria, Assad Has Bush to Thank Big Pharma’s focus on blockbuster cancer drugs squeezes out cheaper treatments. The result, one researcher says: ‘If we’re winning the war on cancer, we’re not winning that fast.’ Michael Retsky awoke from surgery to bad news. “Michael had a mean-looking cancer,” Hrushesky remembers. Retsky didn’t need anyone to tell him his prognosis. In the absence of chemotherapy, there was an 80 percent chance of relapse. Like many cancer patients, Retsky didn’t much like the odds. Seventeen years later and cancer-free, Retsky cannot be entirely sure the treatment cured him, but he believes it likely did. Take Michelle Holmes, an associate professor of medicine at Harvard Medical School. “For some reason a drug that could be patented would get a randomized trial, but aspirin, which has amazing properties, goes unexplored because it’s 99 cents at CVS,” says Holmes. The newer drugs have in some cases shown dramatic life-extending results for patients. No one was interested.